Everence Capital Management Inc Spectrum Pharmaceuticals Inc Transaction History

Everence Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$2.99 - $4.9 $129,766 - $212,660	-43,400 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$2.11 - $3.38 $59,417 - $95,180	28,160 Added 184.78%	43,400 $128,000
Q2 2020 Jul 07, 2020	SELL	$2.11 - $3.38 $59,417 - $95,180	-28,160 Reduced 64.88%	15,240 $53,000
Q1 2020 Jul 09, 2020	BUY	$1.83 - $3.45 $51,532 - $97,152	28,160 Added 184.78%	43,400 $101,000
Q1 2019 May 06, 2019	BUY	$9.08 - $11.84 $138,379 - $180,441	15,240 New	15,240 $163,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.